Alexander Hardy
President, CEO & DirectorMr. Alexander Hardy serves as President, Chief Executive Officer & Director of BioMarin Pharmaceutical Inc. since December 01, 2023 having joined in December 2023. He had been Chief Executive Officer at Genentech, Inc. since March 1, 2019 until 2023 and served as its Director. Mr. Hardy was Head of Global Product Strategy of Roche Holding AG. Mr. Hardy served as Vice President of Sales and Marketing - HER2 Franchise at Genentech, Inc. until febrarury 2012 Mr. Hardy served as a Vice President of Access Solutions, Managed Care and Customer Operations at Genentech Inc. Mr. Alexander Hardy served as Senior Vice President of Impact Business Unit at Genentech, Inc until May 2014. He was Director of Syapse, Inc. since December 2018. Mr. Hardy serves as a member of the Wall Street Journal CEO Council and on the board of directors for the Pharmaceutical Research and Manufacturers of America. Mr. Hardy received a B.A. from the University of Cambridge and an M.B.A. from the University of Michigan’s Ross School of Business.
Positions
- Company NameBioMarin Pharmaceutical Inc.Stock CodeBMRNPositionPresident, CEO & DirectorColleagues
- ITIan T. ClarkIndependent Chair of the Board
- BRBrian R. MuellerCFO & Executive VP of Finance
- CGC. Greg GuyerExecutive VP & CTO
- CHCristin HubbardExecutive VP & Chief Commercial Officer
- GFGregory FribergExecutive VP and Chief Research & Development Officer
- RJRobert J. HombachIndependent Director
- EMElizabeth McKee AndersonIndependent Director
- MJMark Joseph EnyedyIndependent Director
